Reinventing the fight against bacteria,
one phage at a time.

As antimicrobial resistance continues to threaten healthcare systems worldwide, researchers at Near East University are advancing the development of bacteriophage-based therapies targeting multidrug-resistant bacterial infections. The university recently announced the isolation of a third therapeutic bacteriophage, named NEU2025, representing another major step in the institution’s expanding phage therapy program. Dr Ferdiye Taner, neu.edu.tr The newly identified phage was isolated through a collaboration between Near East University and La Trobe University in Australia. Genome analysis classified NEU2025 within the Pbunavirus group, a family of lytic bacteriophages known for infecting Pseudomonas aeruginosa, one of the most clinically problematic opportunistic pathogens associated with hospital-acquired infections and antibiotic resistance. Pseudomonas aeruginosa is particularly concerning because of its remarkable ability to develop multidrug resistance through mechanisms such ...

As bacteriophages and bacteria continue their evolutionary arms race, researchers are uncovering increasingly sophisticated defense strategies used by microbial cells to survive viral infection. A new study published in Nature Communications reveals how a bacterial anti-phage defense system known as Hna can be directly activated by proteins encoded by invading phages, triggering a destructive immune response based on uncontrolled DNA degradation. The Phage Therapy The work, conducted by researchers at the University of Texas at Austin, provides one of the clearest mechanistic descriptions to date of how abortive infection systems function at the molecular level. Unlike classical bacterial immune systems such as CRISPR-Cas or restriction-modification complexes, abortive infection systems do not necessarily aim to save the infected bacterium itself. Instead, they sacrifice the infected cell to prevent viral replication and protect the surrounding bacterial population. The Hna system, or...

As antibiotic resistance continues to challenge healthcare systems worldwide, Switzerland is increasingly re-evaluating the role bacteriophage therapy could play in the treatment of difficult bacterial infections. On May 30, 2026, researchers, physicians, regulators, biotechnology companies, and patient advocates will gather in Lausanne for the Forum Phagothérapie, a public event dedicated to the scientific, clinical, and regulatory future of phage therapy in Switzerland. Register here :  https://phagenforum.ch/fr/events/ Phagen Forum © The event comes at a time when multidrug-resistant infections are becoming increasingly difficult to manage with conventional antibiotics alone. Although antibiotics remain one of the most important tools in modern medicine, bacterial resistance continues to accelerate across hospitals and community healthcare systems. In Switzerland, as in many other countries, some patients suffering from chronic or recurrent infections are running out of eff...

Bacteria and bacteriophages have spent billions of years locked in a relentless evolutionary conflict. Every new viral strategy eventually drives the emergence of a countermeasure, leading to an extraordinary diversity of bacterial defense systems. While CRISPR-Cas and restriction-modification mechanisms remain the most widely recognized antiviral tools in prokaryotes, recent discoveries continue to reveal increasingly sophisticated molecular defenses hidden within bacterial genomes. Among the newest and most intriguing systems is QatABCD, a four-component anti-phage complex whose molecular architecture appears unlike anything previously described. The Phage Therapy A recent structural investigation has now provided the first detailed insights into how the QatABCD system may function at the molecular level. The work focused primarily on two proteins, QatB and QatC, which appear to form the functional core of this defense mechanism. Together, the findings suggest that QatABCD may rely o...

Bacteriophages have always represented a major challenge for the dairy industry. In fermentation systems relying on Streptococcus thermophilus, virulent phages can rapidly infect bacterial starter cultures, disrupt acidification, and compromise the production of yogurt and cheese. Despite decades of research on bacterial antiviral defenses, scientists are still uncovering previously unknown mechanisms shaping the constant evolutionary conflict between bacteria and phages. A recent study now suggests that phage satellites, long considered relatively obscure mobile genetic elements, may play a far more important role in bacterial immunity than previously understood. The Phage Therapy Researchers have discovered that most Streptococcus thermophilus strains contain mobile chromosomal islands known as StCIs, or Streptococcus thermophilus chromosomal islands. These elements belong to the broader family of phage satellites, genetic elements that cannot produce viral particles independently b...

A large-scale European metagenomic study has revealed that the honey bee gut contains a remarkably diverse and previously unexplored population of bacteriophages, suggesting that these viruses may play a far more important role in pollinator biology than previously understood. While most research on honey bee health has traditionally focused on bacterial pathogens, pesticides, parasites, and habitat decline, the new findings indicate that bacteriophages could represent a major ecological component influencing microbial balance, stress adaptation, and colony resilience. The Phage Therapy To investigate the viral ecosystem associated with honey bees, researchers analyzed 450 virus-enriched gut samples collected from bee populations across eight European countries. The study examined multiple gut compartments and seasonal variations, generating one of the most comprehensive datasets ever produced for the analysis of insect-associated phages. Sequencing identified more than 2,300 non-redun...

For more than a century, bacteriophages have existed at the margins of Western medicine, simultaneously recognized as remarkably precise antibacterial agents and dismissed as biologically unpredictable. Today, as antimicrobial resistance continues to escalate worldwide, this perception is beginning to change. Phage therapy is no longer viewed solely as an experimental alternative reserved for compassionate use cases. Instead, it is increasingly being considered a serious therapeutic platform capable of complementing or, in some situations, replacing conventional antibiotics. Yet despite growing enthusiasm, the field now faces a decisive challenge: moving beyond isolated clinical successes toward reproducible, evidence-driven medicine. The Phage Therapy Recent perspectives published in Nature Communications argue that the future of phage therapy will depend less on discovering new phages and more on understanding the biological principles that determine why treatments succeed or fail. T...